English-arkiv - Page 2 of 24

Isofol participates in the ESMO cancer congress

GOTHENBURG, Sweden, October 16, 2025 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company will participate […]

GOTHENBURG, Sweden, September 30, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has successfully

GOTHENBURG, Sweden, September 26, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the transfer of the

GOTHENBURG, Sweden, August 26, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company’s interim report

GOTHENBURG, Sweden, August 21, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), hereby invites investors, analysts and media to

GOTHENBURG, Sweden, July 31, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces new number of shares and votes

GOTHENBURG, Sweden, July 16, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has successfully

GOTHENBURG, Sweden, 4 July 2025 – Isofol Medical AB (“Isofol” or the “Company”) today announces the outcome of the Company’s

GOTHENBURG, Sweden, 17 June 2025 – The Board of Directors of Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (”Isofol” or

GOTHENBURG, Sweden, June 12, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has completed